-
1دورية أكاديمية
المؤلفون: Mosè Parisi, Alessia Manni, Francesca Caputo, Maria Trojano, Damiano Paolicelli
المصدر: Brain and Behavior, Vol 11, Iss 1, Pp n/a-n/a (2021)
مصطلحات موضوعية: adverse effects, immunomodulatory therapy, multiple sclerosis, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2162-3279
-
2
المؤلفون: Domenico M. Mezzapesa, Federica Rizzo, Luigi Chiumarulo, M Savarese, M. Petruzzellis, Mosè Parisi, Nicola Davide Loizzo
المصدر: Clinical Drug Investigation. 41:653-657
مصطلحات موضوعية: medicine.medical_specialty, business.industry, medicine.medical_treatment, Pharmacology toxicology, MEDLINE, General Medicine, Thrombolysis, Pharmacotherapy, medicine, Pharmacology (medical), Endovascular treatment, Intensive care medicine, business, Acute ischemic stroke, Ticagrelor, medicine.drug
-
3
المؤلفون: Damiano Paolicelli, F Caputo, Mosè Parisi, Alessia Manni, Maria Trojano
مصطلحات موضوعية: Interferon beta, business.industry, Multiple sclerosis, Atypical hemolytic uremic syndrome, Immunology, medicine, Late onset, medicine.disease, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::33fae60a0a2a8e785e4674682955abe4
https://doi.org/10.1002/brb3.1930/v2/response1 -
4
المؤلفون: Mosè Parisi, Maria Trojano, Damiano Paolicelli, F Caputo, Alessia Manni
المصدر: Brain and Behavior
Brain and Behavior, Vol 11, Iss 1, Pp n/a-n/a (2021)مصطلحات موضوعية: Adult, Male, Pediatrics, medicine.medical_specialty, Thrombotic microangiopathy, Multiple Sclerosis, Renal function, Reviews, Neurosciences. Biological psychiatry. Neuropsychiatry, Late onset, Review, 050105 experimental psychology, 03 medical and health sciences, Behavioral Neuroscience, 0302 clinical medicine, Multiple Sclerosis, Relapsing-Remitting, Atypical hemolytic uremic syndrome, medicine, Humans, 0501 psychology and cognitive sciences, Adverse effect, Atypical Hemolytic Uremic Syndrome, Retrospective Studies, Neuromyelitis optica, business.industry, Multiple sclerosis, 05 social sciences, Interferon-beta, Eculizumab, medicine.disease, adverse effects, immunomodulatory therapy, business, 030217 neurology & neurosurgery, RC321-571, medicine.drug